A targeted clinical diagnostic test analyzing 1326 genes in solid tumor samples. This panel provides comprehensive genomic profiling for oncology patients to support diagnosis and treatment planning.
Manufactured by
Shenzhen HaploX Biotechnology Co., Ltd.
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Genes 2Me Private Ltd
India · 4 relevant products
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
Medicover Genetics Ltd
Cyprus · 3 relevant products
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 33 relevant matches
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
30 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products